T1	Participants 0 53	Treatment of adults with acute lymphoblastic leukemia
T2	Participants 153 215	Induction therapy for adults with acute lymphoblastic leukemia
T3	Participants 769 827	in patients with Philadelphia chromosome (Ph)-positive ALL
T4	Participants 987 1044	Patients also received consolidation, maintenance therapy
T5	Participants 1207 1242	the median patient age was 43 years
T6	Participants 1244 1284	Responses were evaluated in 164 patients
T7	Participants 1473 1509	More patients on the L-20 arm failed
T8	Participants 2017 2047	ultimate outcomes in adult ALL
